Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEMAZEPAM Cause Multiple organ dysfunction syndrome? 44 Reports in FDA Database

Wake Up Pain-Free — Sleep Like Never Before

Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.

Shop Now — 75% Off

According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Multiple organ dysfunction syndrome have been filed in association with TEMAZEPAM (Temazepam). This represents 0.8% of all adverse event reports for TEMAZEPAM.

44
Reports of Multiple organ dysfunction syndrome with TEMAZEPAM
0.8%
of all TEMAZEPAM reports
41
Deaths
16
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From TEMAZEPAM?

Of the 44 reports, 41 (93.2%) resulted in death, 16 (36.4%) required hospitalization, and 2 (4.5%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEMAZEPAM. However, 44 reports have been filed with the FAERS database.

What Other Side Effects Does TEMAZEPAM Cause?

Toxicity to various agents (1,583) Completed suicide (840) Overdose (759) Drug ineffective (733) Drug abuse (626) Pain (558) Headache (544) Off label use (534) Hyperhidrosis (486) Hypersensitivity (479)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which TEMAZEPAM Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

TEMAZEPAM vs TEMODAR TEMAZEPAM vs TEMOZOLOMIDE TEMAZEPAM vs TEMSIROLIMUS TEMAZEPAM vs TENAMFETAMINE TEMAZEPAM vs TENAPANOR

Related Pages

TEMAZEPAM Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome TEMAZEPAM Demographics